FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4320482010> ?p ?o ?g. }

• W4320482010 abstract "Down syndrome regression disorder (DSRD) is a clinical symptom cluster consisting of neuropsychiatric regression without an identifiable cause. This study evaluated the clinical effectiveness of IVIg and evaluated clinical characteristics associated with relapse after therapy discontinuation. A prospective, multi-center, non-randomized, observational study was performed. Patients met criteria for DSRD and were treated with IVIg. All patients underwent a standardized wean off therapy after 9-12 months of treatment. Baseline, on therapy, and relapse scores of the Neuropsychiatric Inventory Total Score (NPITS), Clinical Global Impression-Severity (CGI-S), and the Bush-Francis Catatonia Rating Scale (BFCRS) were used to track clinical symptoms. Eighty-two individuals were enrolled in this study. Patients had lower BFCRS (MD: -6.68; 95% CI: -8.23, -5.14), CGI-S (MD: -1.27; 95% CI: -1.73, -0.81), and NPITS scores (MD: -6.50; 95% CI: -7.53, -5.47) while they were on therapy compared to baseline. Approximately 46% of the patients (n = 38) experienced neurologic relapse with wean of IVIg. Patients with neurologic relapse were more likely to have any abnormal neurodiagnostic study (χ2 = 11.82, p = 0.001), abnormal MRI (χ2 = 7.78, p = 0.005), and abnormal LP (χ2 = 5.45, p = 0.02), and a personal history of autoimmunity (OR: 6.11, p < 0.001) compared to patients without relapse. IVIg was highly effective in the treatment of DSRD. Individuals with a history of personal autoimmunity or neurodiagnostic abnormalities were more likely to relapse following weaning of immunotherapy, indicating the potential for, a chronic autoimmune etiology in some cases of DSRD." @default.
• W4320482010 created "2023-02-14" @default.
• W4320482010 creator A5002175899 @default.
• W4320482010 creator A5005351965 @default.
• W4320482010 creator A5008144812 @default.
• W4320482010 creator A5009697736 @default.
• W4320482010 creator A5017982767 @default.
• W4320482010 creator A5018895636 @default.
• W4320482010 creator A5021350633 @default.
• W4320482010 creator A5025742516 @default.
• W4320482010 creator A5026799001 @default.
• W4320482010 creator A5033920729 @default.
• W4320482010 creator A5034626049 @default.
• W4320482010 creator A5036914784 @default.
• W4320482010 creator A5040975370 @default.
• W4320482010 creator A5043938578 @default.
• W4320482010 creator A5045541705 @default.
• W4320482010 creator A5054419372 @default.
• W4320482010 creator A5054458451 @default.
• W4320482010 creator A5056619814 @default.
• W4320482010 creator A5067532618 @default.
• W4320482010 creator A5067636859 @default.
• W4320482010 creator A5068518963 @default.
• W4320482010 creator A5068954455 @default.
• W4320482010 creator A5074889967 @default.
• W4320482010 creator A5075037531 @default.
• W4320482010 creator A5079555659 @default.
• W4320482010 creator A5087204433 @default.
• W4320482010 date "2023-02-13" @default.
• W4320482010 modified "2023-09-26" @default.
• W4320482010 title "Immunotherapy Responsiveness and Risk of Relapse in Down Syndrome Regression Disorder" @default.
• W4320482010 cites W1517858621 @default.
• W4320482010 cites W2018466341 @default.
• W4320482010 cites W2053835081 @default.
• W4320482010 cites W2106608941 @default.
• W4320482010 cites W2157340167 @default.
• W4320482010 cites W2169071285 @default.
• W4320482010 cites W2478230774 @default.
• W4320482010 cites W2548945433 @default.
• W4320482010 cites W2583899477 @default.
• W4320482010 cites W2618763538 @default.
• W4320482010 cites W2766826848 @default.
• W4320482010 cites W2904198515 @default.
• W4320482010 cites W2984925361 @default.
• W4320482010 cites W2990211219 @default.
• W4320482010 cites W3029176177 @default.
• W4320482010 cites W3041764411 @default.
• W4320482010 cites W3101792118 @default.
• W4320482010 cites W3197831149 @default.
• W4320482010 cites W3201013741 @default.
• W4320482010 cites W3215549824 @default.
• W4320482010 cites W4210667879 @default.
• W4320482010 cites W4281791251 @default.
• W4320482010 cites W4285590760 @default.
• W4320482010 cites W4289767096 @default.
• W4320482010 cites W3042956174 @default.
• W4320482010 doi "https://doi.org/10.21203/rs.3.rs-2521595/v1" @default.
• W4320482010 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36824719" @default.
• W4320482010 hasPublicationYear "2023" @default.
• W4320482010 type Work @default.
• W4320482010 citedByCount "0" @default.
• W4320482010 crossrefType "posted-content" @default.
• W4320482010 hasAuthorship W4320482010A5002175899 @default.
• W4320482010 hasAuthorship W4320482010A5005351965 @default.
• W4320482010 hasAuthorship W4320482010A5008144812 @default.
• W4320482010 hasAuthorship W4320482010A5009697736 @default.
• W4320482010 hasAuthorship W4320482010A5017982767 @default.
• W4320482010 hasAuthorship W4320482010A5018895636 @default.
• W4320482010 hasAuthorship W4320482010A5021350633 @default.
• W4320482010 hasAuthorship W4320482010A5025742516 @default.
• W4320482010 hasAuthorship W4320482010A5026799001 @default.
• W4320482010 hasAuthorship W4320482010A5033920729 @default.
• W4320482010 hasAuthorship W4320482010A5034626049 @default.
• W4320482010 hasAuthorship W4320482010A5036914784 @default.
• W4320482010 hasAuthorship W4320482010A5040975370 @default.
• W4320482010 hasAuthorship W4320482010A5043938578 @default.
• W4320482010 hasAuthorship W4320482010A5045541705 @default.
• W4320482010 hasAuthorship W4320482010A5054419372 @default.
• W4320482010 hasAuthorship W4320482010A5054458451 @default.
• W4320482010 hasAuthorship W4320482010A5056619814 @default.
• W4320482010 hasAuthorship W4320482010A5067532618 @default.
• W4320482010 hasAuthorship W4320482010A5067636859 @default.
• W4320482010 hasAuthorship W4320482010A5068518963 @default.
• W4320482010 hasAuthorship W4320482010A5068954455 @default.
• W4320482010 hasAuthorship W4320482010A5074889967 @default.
• W4320482010 hasAuthorship W4320482010A5075037531 @default.
• W4320482010 hasAuthorship W4320482010A5079555659 @default.
• W4320482010 hasAuthorship W4320482010A5087204433 @default.
• W4320482010 hasBestOaLocation W43204820101 @default.
• W4320482010 hasConcept C126322002 @default.
• W4320482010 hasConcept C138496976 @default.
• W4320482010 hasConcept C142724271 @default.
• W4320482010 hasConcept C15744967 @default.
• W4320482010 hasConcept C204787440 @default.
• W4320482010 hasConcept C23131810 @default.
• W4320482010 hasConcept C27081682 @default.
• W4320482010 hasConcept C2776000289 @default.
• W4320482010 hasConcept C2778715236 @default.
• W4320482010 hasConcept C71924100 @default.
• W4320482010 hasConcept C83849319 @default.

• next